Health Technology Collaboration | Tissuepathology.com

AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer

Erica Goodpaster — Tue, 19 May 2026 12:26:00 +0000

SINGAPORE, May 18, 2026 /PRNewswire/ — AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance digital pathology capabilities and elevate cancer care across nine Asia markets, a first in the region. This landmark collaboration aims to accelerate the adoption of AI-powered digital and computational pathology through educational and training initiatives and improve […]

The post AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer first appeared on Tissuepathology.com.

Regarding Techcyte and Biobase Partnership on LinkedIn

Erica Goodpaster — Mon, 18 May 2026 12:19:24 +0000

From LinkedIn regarding Techcyte and Biobase partnership Sam Seymour, CPO and Co-Founder at Biobase: I started in digital pathology over 6 years ago at Paige (now Tempus AI). Not a lot has changed since then; digital pathology’s adoption problem has always been the ROI math. The companies that are seeing success in the market have […]

The post Regarding Techcyte and Biobase Partnership on LinkedIn first appeared on Tissuepathology.com.

Aiforia closes a deal with a private diagnostic laboratory in Italy

Erica Goodpaster — Thu, 23 Apr 2026 12:22:10 +0000

Using Aiforia Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed an agreement with Laboratorio di Analisi La Fontana, a private diagnostic laboratory in Italy, to collaborate in AI-powered digital pathology. […]

The post Aiforia closes a deal with a private diagnostic laboratory in Italy first appeared on Tissuepathology.com.

4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program

Erica Goodpaster — Tue, 14 Apr 2026 12:11:22 +0000

4D Path and Daiichi Sankyo: Collaboration to leverage Q-Plasia OncoReader™ (QPOR™) on routine H&E slides to improve patient selection, accelerate clinical development, and deepen biological understanding of response NEWTON, Mass.–(BUSINESS WIRE)–4D Path, a company dedicated to personalizing cancer care through a novel, physics-informed approach to predicting tumor response to therapy, today announced a collaboration with Daiichi […]

The post 4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program first appeared on Tissuepathology.com.

Tribun Health CaloPix Connect: An Open API to Integrate AI into the Digital Pathology Workflow

Erica Goodpaster — Mon, 13 Apr 2026 12:24:14 +0000

From the Tribun Health blog: Discover CaloPix Connect, Tribun Health’s open API to seamlessly integrate AI into pathology workflows, without disruption or added complexity. Artificial Intelligence is rapidly transforming pathology. Automated metastasis detection, biomarker quantification, scoring assistance, therapeutic prediction—the use cases are multiplying and paving the way for faster, more precise diagnoses. Yet one major challenge […]

The post Tribun Health CaloPix Connect: An Open API to Integrate AI into the Digital Pathology Workflow first appeared on Tissuepathology.com.

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications

Erica Goodpaster — Wed, 08 Apr 2026 13:00:10 +0000

BOSTON and COLUMBIA, Md., April 07, 2026 (GLOBE NEWSWIRE) — PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic collaboration to deploy PathAI’s AISight® Dx1 Digital Pathology Platform and various AI algorithm products across the multi-site network. AISight® Dx is PathAI’s […]

The post PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications first appeared on Tissuepathology.com.